High-power red, orange, and green Pr³⁺:LiYF₄ lasers.

Laser experiments with Pr(3+):LiYF4 under excitation with a frequency doubled optically pumped semiconductor laser emitting 5 W at 479 nm were performed at seven different laser wavelengths of 523, 546, 604, 607, 640, 698, and 720 nm. At all these wavelengths the output power exceeded 1 W. The best performance at 523 nm with an output power of 2.

Wide wavelength tunability and green laser operation of diode-pumped Pr3+:KY3F10.

We report on wide spectral tunability of a quasi-continuous wave Pr(3+):KY(3)F(10) laser under InGaN laser diode excitation at 445 nm. The total tuning range exceeded 100 nm in the visible spectral range on several intervals between 521 nm and 737 nm. The broadest continuously tunable region of almost 50 nm extended from 688 nm to 737 nm.

Diode pumped laser operation and spectroscopy of Pr3+:LaF3.

We report on the first results of diode pumped laser operation of Pr3+:LaF3 in a quasi continuous wave (qcw) mode with average output powers of up to 80.0 mW (≈ 161.3 mW qcw) and a maximum slope efficiency of 37% at 719.

Energy levels and emission parameters of the Dy(3+) ion doped into the YPO(4) host lattice.

Single crystals of Dy(3+)-doped YPO(4) have been grown from Pb(2)P(2)O(7) flux and investigated by optical spectroscopy techniques. The energy level scheme of the active ion has been deduced from the low temperature spectra and reproduced by means of a crystal-field calculation. The room temperature absorption spectra have been analysed in the framework of the Judd-Ofelt approach, and the results of this analysis have been applied in a discussion concerning the spectral composition of the visible luminescence.

[Hemodynamic effects of intravenous clonidine in patients with acute myocardial infarction].

To assess the hemodynamic effects of Clonidine in hypertensive patients (pts) with an acute myocardial infarction (AMI), we administered the drug to 12 such patients either in a single bolus (75--150 micrograms in 5 min - 8 pts) or by continuous infusion (0.4--5 micrograms/min - 4 pts). Hemodynamic measurements were obtained by means of a Swan-Ganz thermodilution catheter, before and 60 min after the administration of the drug.